ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

ClinicalTrials.gov ID: NCT07209462

Public ClinicalTrials.gov record NCT07209462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of MRM-3379 in Male Participants With Fragile X Syndrome

Study identification

NCT ID
NCT07209462
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mirum Pharmaceuticals, Inc.
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • High dose of MRM-3379 Drug
  • Low dose of MRM-3379 Drug
  • Low dose of MRM-3379 Open-Label Drug
  • Middle Dose of MRM-3379 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
13 Years to 45 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 21, 2025
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027
Last update posted
May 10, 2026

2025 – 2027

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Southwest Autism Research & Resource Center Phoenix Arizona 85006 Recruiting
Amnova Clinical Research, LLC Irvine California 92604 Recruiting
Children's Hospital of Orange County - Pediatric Subspecialty Orange California 92868 Not yet recruiting
Uc Davis Mind Institute Sacramento California 95817 Not yet recruiting
Children's Hospital Colorado Aurora Colorado 80045 Not yet recruiting
Neurology Miami Florida 33136 Not yet recruiting
Emory University - The Emory Clinic - Clifton Road Atlanta Georgia 30322 Recruiting
Rush University Medical Center-Clinical Operation Chicago Illinois 60612 Recruiting
Kennedy Krieger Institute, John Hopkins School of Medicine Baltimore Maryland 21205 Not yet recruiting
Boston Children's Hospital Boston Massachusetts 02115 Recruiting
UMass Memorial Health Worcester Massachusetts 01655 Recruiting
University of Minnesota Department of Medicine Minneapolis Minnesota 55414 Not yet recruiting
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 42229 Not yet recruiting
Suburban Research Associates Media Pennsylvania 19063 Recruiting
Intermountain Healthcare - Park City Specialty Clinic Salt Lake City Utah 84108 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07209462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07209462 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →